MDSCs and tumor cells upregulate IDO, inducing an immunosuppressive microenvironment through at least two mechanisms: tryptophan depletion and the accumulation of tryptophan catabolites, such as kynurenine, 3-hydroxyanthranilate, and quinolinate (70, 71). This evidence concerns the gene IDO1 and neoplasm.